prof. dr. Nanja van Geel
- ORCID iD
- 0000-0002-3249-8195
Show
Sort by
-
A meta-analysis of the placebo response in vitiligo : causes and consequences for the interpretation of clinical trials
-
Clinician‐reported outcome measures for the assessment of vitiligo : a scoping review
-
- Conference Paper
- C3
- open access
Prognostic value of the vitiligo disease activity signs
-
- Journal Article
- A1
- open access
Initiating value‐based healthcare in psoriasis : proposing a value‐based outcome set for daily clinical practice
-
- Journal Article
- A1
- open access
Vitiligo International Task force for an Agreed List of core data (VITAL) : study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice
-
Biomarkers and clinical indicators of disease activity in vitiligo
-
Credibility and generalization of the minimally important difference concept in dermatology : a scoping review
-
- Journal Article
- A1
- open access
From IL-17 to IFN-γ in inflammatory skin disorders : is transdifferentiation a potential treatment target?
-
- Journal Article
- A1
- open access
The meaning and reliability of minimal important differences (MIDs) for clinician-reported outcome measures (ClinROMs) in dermatology : a scoping review
-
Image analysis systems to calculate the surface area of vitiligo lesions : a systematic review of measurement properties
-
Hot spots of clinical signs of disease activity in Vitiligo
-
The delicate relation between melanocytes and skin immunity : a game of hide and seek
-
- Journal Article
- A1
- open access
The use of lasers in vitiligo, an overview
-
- Journal Article
- A1
- open access
Assessing the dynamic changes in vitiligo : reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)
-
Defining value for patients with psoriasis : development of a patient-driven outcome set for clinical practice
-
Where to find the vitiligo disease activity signs on the body
-
Where to find the vitiligo disease activity signs on the body
-
What vitiligo patients want to know outside the dermatologist's office : an analysis of online search behaviour
-
- Journal Article
- A1
- open access
Patients’ perception of vitiligo severity
-
- Journal Article
- A1
- open access
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism : a systematic review
-
- Journal Article
- A1
- open access
Assessment of non-cultured autologous epidermal cell grafting resuspended in hyaluronic acid for repigmenting vitiligo and piebaldism lesions : a randomized clinical trial
-
Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score
-
Comment on 'An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology'
-
Creating value for psoriasis patients : development of a patient-driven outcome set for clinical practice
(2021) JOURNAL OF INVESTIGATIVE DERMATOLOGY. In Journal of Investigative Dermatology 141(10). p.S160-S160 -
- Journal Article
- A1
- open access
Vaccinations in patients receiving systemic drugs for skin disorders : what can we learn for SARS-Cov-2 vaccination strategies?
-
- Journal Article
- A1
- open access
Validation of a Patient Global Assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES)
-
The reliability of the Self-Assessment Cutaneous Inflammatory Disease Extent Score (SA-CIDES) and the rule of hands to assess the involved body surface area in psoriasis and eczema
-
- Journal Article
- A1
- open access
Reliability and validity of the vitiligo signs of activity score (VSAS)
-
Standardizing serial photography for assessing and monitoring vitiligo : a core set of international recommendations for essential clinical and technical specifications
-
- Journal Article
- A1
- open access
UV light set-ups for vitiligo photography, a comparative study on image quality and ease of use
-
- Journal Article
- A1
- open access
Learning from success and failure: biologics for non-approved skin diseases
-
IL‐17A is not a treatment target in progressive vitiligo
-
Comparison of methods to estimate the affected body surface area and the dosage of topical treatments in psoriasis and atopic dermatitis : the advantage of a picture‐based tool
-
Clinical visible signs of disease activity in vitiligo : a systematic review and meta‐analysis
-
Validation of a physician global assessment tool for vitiligo extent : results of an international vitiligo expert meeting
-
- Journal Article
- A1
- open access
Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression
-
Reference method for digital surface measurement of target lesions in vitiligo : a comparative analysis
-
Targeting the IL-23/IL-17 pathway in psoriasis : the search for the good, the bad and the ugly
-
Patient selection, pre- and postoperative information in surgical therapies for vitiligo
-
Melanocyte and melanogenesis : applied anatomy and physiology
-
Introduction
-
The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo
-
Validation study of the Vitiligo Extent Score-plus
-
Critical appraisal of the oxidative stress pathway in vitiligo : a systematic review and meta-analysis
-
Vitiligo and lupus : more similarities than meets the eye
-
Vitiligo : an update on pathophysiology and treatment options
-
Biomarkers of disease activity in vitiligo : a systematic review
-
Alterations of CXCL12 in serum of patients with vitiligo
-
Segmental vitiligo
-
Meeting report: Vitiligo Global Issues Consensus Conference Workshop 'Outcome measurement instruments' and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd